Patriot Berry Farms (PBFI) Announces Name Change to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Patriot Berry Farms (PBFI) Announces Name Change to Cyberfort Software Inc., Acquisition of first IP and a move into the Cyber Security Market

SAN FRANCISCO, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Patriot Berry Farms Inc. (OTCQB:PBFI) is pleased to announce completion of the initial steps required in order to enter the Cyber Security industry, commencing with a name change application, filed with the SEC on September 15 th 2016. The company will soon be known as Cyberfort Software Inc. and will target the $122.45 billion 1 Cyber Security market, starting with its purchase of an innovative iOS and MacOS privacy and security application.

Patriot Berry Farms Becomes Cyberfort Software Inc. The company has initiated the name-changing process, a transition designed to help Cyberfort Software position itself in the Cyber Security market. The complete transition process is expected to be completed by October 14 th 2016, with a new ticker symbol to be announced in due course.

Moving into The Ever-Expanding Cyber Security Market As the Cyber Security market continues to grow and is expected to top $200 billion 1 over the next five years, the company will immediately start to refine and develop its initial software, whilst working to nurture and grow new technologies in order to realize Cyberfort’s market share in this exciting sector.

Commenting on the new direction, Daniel Cattlin, CEO, said: “We are extremely pleased to announce this new acquisition and change of direction. We believe this is a tremendous opportunity to grow in such an exciting sector, we’ve secured an incredible technology and we’re seriously excited.”

Purchasing and Developing New IPs Cyberfort Software Inc. has now signed an agreement to acquire its first Cyber Security IP. This first acquisition, known as “Vivio,” is an innovative Artificial Intelligence(AI)-driven application, enhancing the security and privacy of users by focusing on Ad-Blocking and Content Filtering. The Vivio app enables users to experience browsing the web faster and cleaner, without compromising their online safety. Vivio not only removes ads from the websites users visit in Safari, it also has been shown to save on data traffic and roaming data traffic costs up to 50% and as a result allows longer battery life of portable devices.

Cyberfort will immediately begin utilizing Vivio´s existing users as base to test and develop a suite of enterprise tools and security solutions.  

Hiring Cyber Security Experts Along with its initial acquisition, Cyberfort aims to launch a strategic hiring campaign to bring in talent from a variety of Cyber Security and IT development companies. The company will soon announce a list of new employees as well as industry leading advisory board members.

New Headquarters Location and Online Presence Cyberfort has relocated its headquarters to the heart of the high-tech industry and is now based in San Francisco, California.

The company has just completed a new website containing all the information pertaining to the team, new IP acquisitions, market positioning, future developments and investor information.

Please visit   www.cyberfortsoftware.com

The Vivio App can be downloaded through ITunes: https://itunes.apple.com/gb/app/vivio-adblock...71088?mt=8

About Cyberfort Software, Inc. Cyberfort Software Inc. is a Cyber Security Technology Company dedicated to improving the digital lives, privacy and security of end users and organizations. It targets the worldwide Cyber Security market by specializing in the acquisition and development of security software, content filtering and ad-blocking technology.

Footnotes 1 http://www.marketsandmarkets.com/PressRelease...curity.asp

This press release contains statements that are forward-looking and which involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in question are based on Cyberfort Software Inc’s current expectations and projections about future events, based on information currently available. The forward-looking statements found in this press release may also include statements relating to Patriot Berry Farms, Inc. and Cyberfort Software Inc.’s anticipated financial performance, business prospects, new developments, strategies, and similar matters. Cyberfort Software, Inc. provides no assurance regarding the actual outcome of the events contemplated by any forward looking statements included in this release. Cyberfort Software, Inc. disclaims any obligation to update any of its forward-looking statements, except as may be required by law.

Contact details: - Cyberfort Software, Inc. 388 Market Street, Suite 1300 San Francisco, CA 94111 info@cyberfortsoftware.com ir@cyberfortsoftware.com www.cyberfortsoftware.com Office: (415) 295 4507 Fax: (415) 295 4459 Toll Free Investor Line: (800) 543-6974

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading